Atria Investments Inc Sells 882 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Atria Investments Inc trimmed its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 4.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,073 shares of the company’s stock after selling 882 shares during the quarter. Atria Investments Inc’s holdings in Bath & Body Works were worth $641,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in Bath & Body Works by 4.2% in the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock valued at $1,370,458,000 after acquiring an additional 1,102,124 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of Bath & Body Works by 328.7% during the third quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company’s stock valued at $34,153,000 after acquiring an additional 820,379 shares in the last quarter. UniSuper Management Pty Ltd raised its holdings in Bath & Body Works by 576.9% in the 1st quarter. UniSuper Management Pty Ltd now owns 22,799 shares of the company’s stock worth $1,140,000 after purchasing an additional 19,431 shares in the last quarter. New York State Teachers Retirement System lifted its holdings in Bath & Body Works by 18.1% in the third quarter. New York State Teachers Retirement System now owns 266,235 shares of the company’s stock worth $8,498,000 after buying an additional 40,793 shares during the period. Finally, Renaissance Technologies LLC lifted its stake in shares of Bath & Body Works by 152.7% in the 2nd quarter. Renaissance Technologies LLC now owns 901,133 shares of the company’s stock valued at $35,189,000 after purchasing an additional 544,599 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Gina Boswell bought 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.27% of the stock is owned by insiders.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $30.45 on Wednesday. The firm has a market cap of $6.67 billion, a price-to-earnings ratio of 7.37, a price-to-earnings-growth ratio of 1.00 and a beta of 1.79. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The firm’s 50 day moving average price is $30.34 and its two-hundred day moving average price is $36.18.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. As a group, equities analysts predict that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.63%. Bath & Body Works’s dividend payout ratio (DPR) is currently 19.37%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on BBWI shares. Bank of America lowered their price target on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. The Goldman Sachs Group lowered their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a research report on Thursday, August 29th. JPMorgan Chase & Co. dropped their target price on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Barclays downgraded shares of Bath & Body Works from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $31.00 to $28.00 in a research report on Friday, November 8th. Finally, Raymond James cut their price objective on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $42.44.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.